An Advance Care Planning Programme for Persons With Early Stage Dementia in the Community
NCT ID: NCT04491578
Last Updated: 2023-03-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
100 participants
INTERVENTIONAL
2021-01-09
2022-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of An ACP Programme for Older People With Early Dementia
NCT05240664
Promoting Advance Care Planning for Persons With Early-stage Dementia in the Community: a Feasibility Trial
NCT04513106
Preparing Surrogates of Dementia Patients Through an Advance Care Planning Intervention
NCT06152120
A Community-based Advance Care Planning Programme for Patients With Advanced Disease
NCT02068651
Strengthen Family Members' Understanding of Advance Care Planning With a Nurse-led, Motivational Interview
NCT05901506
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ACP programme
It is a theory-driven ACP programme specifically designed for PWEDs or persons with MCI and their family caregivers. The intervention is underpinned by the Bandura's self-efficacy model and shared decision-making model.
ACP programme "Have a Say"
Each dyad of participants will receive a 4-session ACP programme, which consists of educational components, guided reflection, and dyadic ACP discussion, guided by ACP facilitators and an ACP booklet. It is composed of 2 group-based sessions and 2 dyadic discussions. One hour for each session. The group-based sessions are nurse-led, in which dyads of participants will be provided with information about the trajectory of dementia, their future healthcare needs and caring options. Their values and care preferences on future care will be elicited in a consistent manner. The dyadic sessions are led by trained ACP facilitator. Dyads of participants will be supported to have an individualized ACP discussion. By the end of the programme, each dyad of participants will be given an ACP booklet documenting the ACP process.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ACP programme "Have a Say"
Each dyad of participants will receive a 4-session ACP programme, which consists of educational components, guided reflection, and dyadic ACP discussion, guided by ACP facilitators and an ACP booklet. It is composed of 2 group-based sessions and 2 dyadic discussions. One hour for each session. The group-based sessions are nurse-led, in which dyads of participants will be provided with information about the trajectory of dementia, their future healthcare needs and caring options. Their values and care preferences on future care will be elicited in a consistent manner. The dyadic sessions are led by trained ACP facilitator. Dyads of participants will be supported to have an individualized ACP discussion. By the end of the programme, each dyad of participants will be given an ACP booklet documenting the ACP process.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* being Chinese,
* being a Cantonese speaker,
* having a Global Deterioration Scale score 3 or 4,
* having a designated family caregiver willing to participate in this study
Exclusion Criteria
* mentally incompetent,
* received an ACP intervention,
* have previously signed an advance directive,
* have other life-limiting chronic illnesses with a life expectancy of less than 6 months.
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chinese University of Hong Kong
OTHER
Food and Health Bureau, Hong Kong
OTHER_GOV
Hong Kong Metropolitan University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ms Cheryl Yeung Chi Yan
Senior Lecturer
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Chi Yan Cheryl Yeung, MN
Role: PRINCIPAL_INVESTIGATOR
Chinese University of Hong Kong
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
HKSKH Lok Man Alice Kwok Integrated Service Centre
Kowloon, , Hong Kong
Hong Kong Christian Service
Kowloon, , Hong Kong
Yang Memorial Methodist Social Service Choi Hung Community Centre for Senior Citizens
Kowloon, , Hong Kong
The Neighbourhood Advice-Action Council Sham Shui Po District Elderly Community Centre
Sham Shui Po, , Hong Kong
Jockey Club Centre for Positive Ageing
Shatin, , Hong Kong
The Neighbourhood Advice- Action Council Ma On Shan Neighbourhood Elderly Centre
Shatin, , Hong Kong
The Neighbourhood Advice-Action Council Tuen Mun District Integrated Services Centre for the Elderly
Tuenmen, , Hong Kong
Yau On Lutheran Centre for the Elderly
Tuenmen, , Hong Kong
HKSKH Chuk Yuen Canon Martin District Elderly Community Centre
Wong Tai Sin, , Hong Kong
Pentecostal Church of Hong Kong Ltd.Choi Wan Neighbourhood Elderly Centre
Wong Tai Sin, , Hong Kong
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HMRF 03180198
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.